Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved

Women with β-thalassemia (BT) and sickle cell disease (SCD) have a high risk of infertility and premature ovarian insufficiency. Different fertility preserving strategies, including ovarian tissue cryopreservation (OTC) and oocyte cryopreservation has been considered, and healthy babies have been bo...

Full description

Bibliographic Details
Main Authors: Linn Salto Mamsen, Stine Gry Kristensen, Susanne Elisabeth Pors, Jane Alrø Bøtkjær, Erik Ernst, Kirsten Tryde Macklon, Debra Gook, Ajay Kumar, Bhanu Kalra, Claus Yding Andersen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2020.593718/full
id doaj-cd166cebbee546fd9965b8afd380cbbb
record_format Article
spelling doaj-cd166cebbee546fd9965b8afd380cbbb2021-01-15T11:28:16ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-01-011110.3389/fendo.2020.593718593718Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue CryopreservedLinn Salto Mamsen0Stine Gry Kristensen1Susanne Elisabeth Pors2Jane Alrø Bøtkjær3Erik Ernst4Kirsten Tryde Macklon5Debra Gook6Debra Gook7Ajay Kumar8Bhanu Kalra9Claus Yding Andersen10Laboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkDepartment of Obstetrics and Gynaecology, Regional Hospital Horsens, Horsens, DenmarkThe Fertility Clinic, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkReproductive Services and Melbourne IVF, Royal Women’s Hospital, Parkville, VIC, AustraliaDepartment of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC, AustraliaAnsh Labs LLC, Webster, TX, United StatesAnsh Labs LLC, Webster, TX, United StatesLaboratory of Reproductive Biology, The Juliane Marie Centre for Women, Children, and Reproduction, Copenhagen University Hospital, Rigshospitalet, Copenhagen, DenmarkWomen with β-thalassemia (BT) and sickle cell disease (SCD) have a high risk of infertility and premature ovarian insufficiency. Different fertility preserving strategies, including ovarian tissue cryopreservation (OTC) and oocyte cryopreservation has been considered, and healthy babies have been born after successful OTC and transplantation. We evaluated follicle number and follicle health in ovarian tissue from a cohort of BT and SCD patients who underwent OTC before the age of 18 years. Patients undergoing OTC from 2002 to 2019 were included. A total of 14 girls and adolescents with BT and four with SCD, aged 2.8–17.4 years at OTC were included together with a reference group of 43 girls and adolescents with non-anemia diseases considered to have normal ovaries aged 0.6–17.9 years at OTC. Ovarian follicle density was measured in cortex biopsies and compared to the reference group. Expression of proteins associated with follicular health was evaluated using immunohistochemistry. Follicles were detected in the ovarian cortex biopsies from all patients with BT and SCD. The follicle densities were within the 95% prediction interval of the reference group in all cases. A similar expression of six proteins essential for follicular health was detected using immunohistochemistry in BT, SCD, and references. OTC should be considered an option for young girls and adolescents with BT and SCD.https://www.frontiersin.org/articles/10.3389/fendo.2020.593718/fullovarian tissue cryopreservationfertility preservationthalassemiasickle cell diseasegenetic diseases
collection DOAJ
language English
format Article
sources DOAJ
author Linn Salto Mamsen
Stine Gry Kristensen
Susanne Elisabeth Pors
Jane Alrø Bøtkjær
Erik Ernst
Kirsten Tryde Macklon
Debra Gook
Debra Gook
Ajay Kumar
Bhanu Kalra
Claus Yding Andersen
spellingShingle Linn Salto Mamsen
Stine Gry Kristensen
Susanne Elisabeth Pors
Jane Alrø Bøtkjær
Erik Ernst
Kirsten Tryde Macklon
Debra Gook
Debra Gook
Ajay Kumar
Bhanu Kalra
Claus Yding Andersen
Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved
Frontiers in Endocrinology
ovarian tissue cryopreservation
fertility preservation
thalassemia
sickle cell disease
genetic diseases
author_facet Linn Salto Mamsen
Stine Gry Kristensen
Susanne Elisabeth Pors
Jane Alrø Bøtkjær
Erik Ernst
Kirsten Tryde Macklon
Debra Gook
Debra Gook
Ajay Kumar
Bhanu Kalra
Claus Yding Andersen
author_sort Linn Salto Mamsen
title Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved
title_short Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved
title_full Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved
title_fullStr Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved
title_full_unstemmed Consequences of β-Thalassemia or Sickle Cell Disease for Ovarian Follicle Number and Morphology in Girls Who Had Ovarian Tissue Cryopreserved
title_sort consequences of β-thalassemia or sickle cell disease for ovarian follicle number and morphology in girls who had ovarian tissue cryopreserved
publisher Frontiers Media S.A.
series Frontiers in Endocrinology
issn 1664-2392
publishDate 2021-01-01
description Women with β-thalassemia (BT) and sickle cell disease (SCD) have a high risk of infertility and premature ovarian insufficiency. Different fertility preserving strategies, including ovarian tissue cryopreservation (OTC) and oocyte cryopreservation has been considered, and healthy babies have been born after successful OTC and transplantation. We evaluated follicle number and follicle health in ovarian tissue from a cohort of BT and SCD patients who underwent OTC before the age of 18 years. Patients undergoing OTC from 2002 to 2019 were included. A total of 14 girls and adolescents with BT and four with SCD, aged 2.8–17.4 years at OTC were included together with a reference group of 43 girls and adolescents with non-anemia diseases considered to have normal ovaries aged 0.6–17.9 years at OTC. Ovarian follicle density was measured in cortex biopsies and compared to the reference group. Expression of proteins associated with follicular health was evaluated using immunohistochemistry. Follicles were detected in the ovarian cortex biopsies from all patients with BT and SCD. The follicle densities were within the 95% prediction interval of the reference group in all cases. A similar expression of six proteins essential for follicular health was detected using immunohistochemistry in BT, SCD, and references. OTC should be considered an option for young girls and adolescents with BT and SCD.
topic ovarian tissue cryopreservation
fertility preservation
thalassemia
sickle cell disease
genetic diseases
url https://www.frontiersin.org/articles/10.3389/fendo.2020.593718/full
work_keys_str_mv AT linnsaltomamsen consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
AT stinegrykristensen consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
AT susanneelisabethpors consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
AT janealrøbøtkjær consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
AT erikernst consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
AT kirstentrydemacklon consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
AT debragook consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
AT debragook consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
AT ajaykumar consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
AT bhanukalra consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
AT clausydingandersen consequencesofbthalassemiaorsicklecelldiseaseforovarianfolliclenumberandmorphologyingirlswhohadovariantissuecryopreserved
_version_ 1724337111562190848